TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) has provided an announcement.
Shandong Xinhua Pharmaceutical Company Limited has announced the receipt of the Drug Registration Certificate for its Alendronate Sodium Oral Solution, approved by the National Medical Products Administration. This approval allows the company to produce and sell the drug, enhancing its product portfolio and potentially strengthening its market position in the pharmaceutical industry.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a pharmaceutical company based in China, specializing in the production and distribution of prescription drugs. The company focuses on chemical drug production and has a significant presence in the pharmaceutical industry.
Average Trading Volume: 2,936,545
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.75B
See more insights into 0719 stock on TipRanks’ Stock Analysis page.